Enclomiphene purity and testing: what buyers should verify

Last updated 2026-07-27

Is enclomiphene FDA-approved, and does that affect purity testing?

No. Enclomiphene citrate was developed under the brand name Androxal by Repros Therapeutics, and it never made it across the finish line. The FDA issued Complete Response Letters in 2012 and 2016 asking for more safety and efficacy data, and Repros eventually shelved the program ^[1]. There is no FDA-approved enclomiphene product sold in the United States today. That matters directly for purity testing, because approved drugs get manufactured in FDA-inspected facilities under Current Good Manufacturing Practice (CGMP) rules, with the agency reviewing the manufacturing process itself before approval ^[2]. Compounded drugs skip that pre-market review entirely. The compounding pharmacy is responsible for its own quality systems, and the FDA's oversight is more about facility registration and adverse event reporting than pre-approving each formulation. So when you buy enclomiphene, you are buying a compounded product, full stop. That's not automatically bad, doctors prescribe compounded drugs every day for good reasons, but it does mean the purity question shifts from "did the FDA approve this formula" to "which pharmacy made this batch, and what did they test for."

Who actually regulates compounding pharmacies that make enclomiphene?

Two different tiers, and the difference matters more than most buyers realize. Section 503A of the Federal Food, Drug, and Cosmetic Act covers traditional compounding pharmacies that make patient-specific prescriptions; they're regulated primarily by state boards of pharmacy, with lighter federal oversight ^[3]. Section 503B covers "outsourcing facilities," which can compound in bulk without individual prescriptions, but in exchange they must register with the FDA and follow CGMP, and they're subject to routine FDA inspection ^[3]. If a pharmacy is 503B-registered, you can actually look it up on the FDA's public list of registered outsourcing facilities ^[4]. That's a real, checkable fact, not a marketing claim. A 503A pharmacy compounding for an individual prescription won't show up there, because it doesn't have to register the same way; you're relying instead on state licensure and the pharmacy's own quality practices. Neither tier means the FDA is testing every vial of enclomiphene for purity. It means the facility is operating under a known regulatory framework instead of none at all. That's the realistic bar: not "is this FDA-approved" (it isn't, and can't be, since Androxal never got there), but "is this pharmacy operating inside a system that has actual accountability."

What lab tests should a legitimate enclomiphene product have?

Three things worth asking about specifically: identity, potency, and sterility/purity contaminant screening. Identity testing confirms the vial actually contains enclomiphene citrate and not something else (or nothing). The gold-standard method here is high-performance liquid chromatography (HPLC), which separates and quantifies compounds in a sample with enough precision to catch substitutions or degraded product. Potency testing (often reported as percent of labeled strength) tells you whether the concentration matches the label, USP general chapter <795> and <797> set compounding quality standards that reputable pharmacies use as their baseline for non-sterile and sterile preparations respectively ^[5]. For sterile injectable or reconstituted products specifically, USP <797> governs sterile compounding environments, and beyond-use dating, environmental monitoring, and endotoxin testing all fall under that umbrella ^[5]. If a vendor is selling something that gets reconstituted and injected, sterility testing isn't optional practice, it's the difference between a clean product and a contamination risk. A legitimate Certificate of Analysis (CoA) should show the lot number, test date, method used (HPLC is the credible one), and the actual measured potency, more than a pass/fail checkbox. If a CoA has no lot number tying it to what's actually in your hand, it's not proof of anything, it's a PDF.

How is enclomiphene different from clomiphene, and does that affect what you're buying?

This confuses almost everyone, so it's worth being precise. Clomiphene citrate (brand name Clomid) is actually a mixture of two isomers: enclomiphene and zuclomiphene, roughly in a 62:38 ratio ^[6]. Enclomiphene is the trans-isomer and is the one doing most of the estrogen-receptor-antagonist work at the hypothalamus that drives LH and FSH up. Zuclomiphene, the cis-isomer, has a much longer half-life (it can persist for weeks) and acts more like a weak estrogen agonist in some tissues ^[6]. When a compounding pharmacy sells "enclomiphene," they're supposed to be selling the isolated trans-isomer, not the mixture. That's the entire premise of enclomiphene monotherapy: proponents argue that isolating enclomiphene avoids the zuclomiphene-related side effects sometimes blamed for mood changes and visual disturbances seen with clomiphene, though the isomer-specific side effect data is thinner than the marketing suggests ^[6]. Here's the purity question that actually matters and that most buyers never ask: does the CoA confirm isomer purity, or just "clomiphene-family compound present"? A sloppy or dishonest compounder could theoretically sell you standard clomiphene citrate (the isomer mixture) relabeled as enclomiphene, and a basic test that doesn't distinguish isomers wouldn't catch it. HPLC methods capable of isomer separation exist and are the only way to actually verify you're getting isolated enclomiphene rather than relabeled Clomid. Ask directly whether the pharmacy's testing method distinguishes the isomers. If they can't answer that question, that's your answer.

Does enclomiphene really preserve fertility better than TRT, and how does that relate to purity?

This is the reason most men are looking at enclomiphene in the first place, so it's worth separating the pharmacology from the purity question. Exogenous testosterone (standard TRT, injections, gels, pellets) suppresses the hypothalamic-pituitary-gonadal axis: the brain senses testosterone is already high, so it cuts LH and FSH output, and the testes scale back both testosterone production and sperm production. That's well established and is why TRT is a recognized cause of iatrogenic infertility ^[7]. Enclomiphene works differently. It blocks estrogen receptors at the hypothalamus, which the brain reads as "estrogen is low," so it increases GnRH pulses, which raises LH and FSH, which stimulates the testes to make more of their own testosterone, while keeping the signaling loop that also supports sperm production intact. A small clinical trial (n=12) published in the Journal of Sexual Medicine found enclomiphene raised testosterone into the normal range while maintaining sperm concentration and LH/FSH levels, in contrast with a testosterone gel comparison arm that suppressed sperm parameters ^[8]. That's a real, citable finding, but it's a small, short study, not a large outcomes trial proving fertility preservation over years of use, and nobody should promise a reader that outcome as guaranteed. Now, why does this connect to purity? Because the entire fertility-preservation rationale depends on the vial actually containing pure, correctly-dosed enclomiphene and not a variable mix contaminated with zuclomiphene or under/over-dosed relative to label claim. A batch with meaningfully lower potency than labeled might undertreat and leave testosterone low; a batch contaminated with the zuclomiphene isomer starts drifting back toward standard clomiphene's profile. Purity isn't a side detail here, it's structurally connected to whether the drug does the one thing that differentiates it from TRT in the first place. If you're timing a cycle around fertility, Enclomiphene Direct dosage and cycle planning both assume the vial is what the label says.

What red flags suggest a vendor is cutting corners on purity?

A few practical tells, in order of how often they show up. No prescription required. Legitimate compounded enclomiphene requires a prescriber's order; a 503A pharmacy cannot legally dispense it without one. If a site sells vials with no medical evaluation at all, you're not buying pharmacy-grade product, you're buying research chemical grade material with a marketing wrapper, and that supply chain has essentially zero purity accountability. Generic or stock CoAs. A CoA that isn't tied to a specific lot number, or that looks identical across every product on the site, is decorative. Real CoAs vary by batch because real manufacturing varies by batch. No named pharmacy. If a company won't tell you which licensed pharmacy is actually compounding and dispensing the product, that's a serious flag. Reputable telehealth-to-pharmacy models name their fulfillment partner because they have nothing to hide about it. Price that's dramatically below the going rate. Compounding costs money: raw material sourcing, sterile facility overhead, and testing all add up. A price that's a fraction of the market range usually means one of those steps got skipped, and testing is often the first corner cut because it's invisible to the buyer until something goes wrong. No clear reconstitution or handling guidance. This isn't strictly a purity issue, but vendors that treat the product casually on dosing and storage tend to treat manufacturing casually too. If you do get a legitimate vial, how to reconstitute Enclomiphene Direct correctly still matters for keeping it stable and sterile after the pharmacy's job is done.

How can I verify a compounding pharmacy is legitimate before I order?

A few concrete, checkable steps, not vibes. First, check the pharmacy's state board of pharmacy license. Every state maintains a searchable license database; the National Association of Boards of Pharmacy also maintains a Verified Pharmacy Program (VIPPS/VIPPS-accredited) list of accredited pharmacy websites you can cross-reference . Second, if the vendor claims 503B outsourcing facility status, check the FDA's registered outsourcing facilities list directly, it's a public document the agency updates ^[4]. If they claim it and aren't on the list, that's disqualifying. Third, ask for the actual CoA for your lot before you commit to a full cycle purchase, not a generic "here's what we test for" page. A pharmacy confident in its process will produce this without friction. Fourth, confirm a licensed prescriber is actually reviewing your case. Legitimate telehealth-to-pharmacy models require bloodwork and a prescriber sign-off before dispensing; that's not bureaucratic friction, it's the mechanism that keeps the product inside a regulated supply chain instead of a gray-market one.

What does a compounding quality standard like USP <795>/<797> actually guarantee?

Less than people assume, and it's worth being honest about that. USP general chapters <795> (non-sterile compounding) and <797> (sterile compounding) are quality standards published by the United States Pharmacopeia, and most state boards of pharmacy have adopted them, in whole or in part, as the baseline for licensed compounding practice ^[5]. They cover things like personnel training, environmental controls, beyond-use dating, and testing protocols. They are not a government guarantee, though. USP is a nonprofit standards-setting body, not a regulator; enforcement happens through state boards adopting the standards into law and then inspecting pharmacies against them. So "USP <797> compliant" is a real, meaningful claim, it tells you the pharmacy is operating under a recognized sterile compounding standard, but it's not the same as an FDA approval, and it doesn't mean an independent lab re-tested your specific vial. The honest framing: USP compliance is a floor, a sign the pharmacy is operating like a real pharmacy rather than a garage operation. A CoA showing your specific lot's actual HPLC potency result is the ceiling, the closest thing to real proof you'll get as a consumer.

Does enclomiphene need refrigeration or special handling that affects purity over time?

Compounded enclomiphene, especially reconstituted injectable formulations, is typically more sensitive to heat, light, and time than a mass-manufactured tablet would be, precisely because it hasn't gone through the same stability testing an FDA-approved product undergoes before labeling. Compounding pharmacies assign a "beyond-use date" (BUD) rather than a manufacturer's expiration date, and that BUD is often considerably shorter, because it's based on USP stability guidance rather than long-term stability studies specific to that formulation ^[5]. Practically: keep it in the temperature range your pharmacy specifies (often refrigerated once reconstituted), out of direct light, and don't use it past the BUD on your label even if the vial looks fine. A vial that started pure can degrade in ways you can't see or smell. This is also where Enclomiphene Direct injection sites and handling practices intersect with purity: contamination introduced during draw-up (dirty needles, non-alcohol-swabbed stoppers, multiple entries into one vial) can undo a perfectly clean manufacturing process. Purity isn't just what left the pharmacy; it's also what happens in your hands afterward.

What's a realistic price range for compounded enclomiphene, and does price signal purity?

Pricing varies by pharmacy, dose, and whether it's bundled with a telehealth consult, but compounded enclomiphene commonly runs somewhere in the range of $60 to $150+ per month depending on dose and provider model; exact pricing isn't standardized because, again, there's no single approved product with a set price the way there would be for an FDA-approved generic. Price alone is a weak purity signal on its own, cheap doesn't necessarily mean impure and expensive doesn't guarantee purity, but a price far below the market range paired with no prescription requirement is a real combination of red flags worth taking seriously. The more useful signal is what the price includes: bloodwork, prescriber review, a named licensed pharmacy, and accessible lot-specific testing all cost money and time to provide. A bare-bones price with none of that infrastructure is telling you something about where the corners got cut.

Is it safe to trust vendors that don't disclose their fulfilling pharmacy?

No, and this is close to a bright line. A legitimate telehealth-to-prescription model has nothing to gain by hiding which pharmacy fills the order, because the pharmacy's licensure is a selling point, not a liability. Enclomiphene Direct, for example, is provider-reviewed and discloses its fulfilling pharmacy partner as part of that process, which is the structure worth looking for regardless of which company you end up using. If a company is cagey about naming the pharmacy, ask why. There are only a few honest answers (proprietary business reasons rarely apply to a compounding relationship the way they might to a manufacturing trade secret), and "we don't want you checking their license" is the uncomfortable one that fits the pattern most often.

What should I ask my provider before starting enclomiphene?

A short, specific list beats a vague "is this safe" conversation. Ask which pharmacy compounds the prescription and whether it's 503A or 503B. Ask whether baseline labs (total and free testosterone, LH, FSH, estradiol) are required before starting, since dosing decisions and even the decision to use enclomiphene at all should be lab-driven, not guessed. Ask what monitoring schedule follows, most protocols recheck labs at 4 to 8 weeks. If fertility is a specific goal (more than testosterone symptoms), ask about baseline semen analysis too, since the fertility-preservation argument for enclomiphene is about the axis staying intact, not a guarantee of a specific sperm count outcome. For the practical mechanics once you've got a legitimate prescription in hand, see Enclomiphene Direct how to inject, Enclomiphene Direct dosage calculator, and Enclomiphene Direct cycle length for how a typical protocol is structured once purity and sourcing are settled.

Frequently asked questions

Is enclomiphene FDA-approved?

No. Enclomiphene citrate was studied under the brand name Androxal, but the FDA issued Complete Response Letters in 2012 and 2016 and the drug never gained approval ^[1]. Everything sold today is compounded by licensed pharmacies under state and, in some cases, FDA outsourcing facility oversight, not an approved commercial product.

What's the difference between enclomiphene and clomiphene?

Clomiphene citrate (Clomid) is a roughly 62:38 mixture of two isomers, enclomiphene and zuclomiphene ^[6]. Enclomiphene is the isolated trans-isomer, thought to do most of the testosterone-raising work, while zuclomiphene lingers much longer and is linked to some of clomiphene's side effect profile. Enclomiphene monotherapy isolates the former.

Does enclomiphene preserve fertility better than TRT?

It works through a different mechanism that keeps the LH/FSH signaling loop active instead of shutting it down like exogenous testosterone does. A small trial (n=12) found it maintained sperm parameters while raising testosterone ^[9], but that's limited data, not a guarantee. Exogenous TRT is well documented to suppress sperm production ^[8].

How do I know if a compounding pharmacy is legitimate?

Check the pharmacy's state board of pharmacy license and cross-reference NABP's Verified Pharmacy Program list ^[10]. If they claim 503B outsourcing facility status, verify it against the FDA's registered facility list ^[4]. Legitimate providers require a prescription and disclose which pharmacy fills the order.

What lab testing should a legit enclomiphene product have?

Look for HPLC-based identity and potency testing tied to a specific lot number, plus sterility testing for injectable formulations, ideally produced under USP <795>/<797> compounding standards ^[5]. A generic, undated Certificate of Analysis that isn't tied to your batch isn't meaningful proof.

Can a vendor sell regular clomiphene and call it enclomiphene?

Yes, that's a real risk if testing doesn't distinguish isomers. Basic assays might confirm "a clomiphene-family compound is present" without proving isolation of the trans-isomer. Ask specifically whether the pharmacy's HPLC method separates enclomiphene from zuclomiphene; if they can't answer, treat that as a red flag.

How much does compounded enclomiphene typically cost?

Commonly somewhere in the $60 to $150+ per month range depending on dose and whether a telehealth consult is bundled in, though pricing isn't standardized since there's no single FDA-approved product setting a benchmark price. Price far below that range combined with no prescription requirement is a real warning sign.

Does enclomiphene need refrigeration?

Many compounded, reconstituted formulations do require refrigeration and protection from light, and pharmacies assign a shorter beyond-use date rather than a long shelf-stable expiration, based on USP stability guidance ^[5]. Follow your specific pharmacy's storage instructions and don't use product past the labeled beyond-use date.

Is a Certificate of Analysis proof that a product is pure?

Only if it's specific to your lot, dated, names the test method (HPLC is the credible standard), and shows an actual measured potency rather than a bare pass/fail. A generic CoA reused across every batch or product on a site proves nothing about what's actually in your vial.

Who regulates compounding pharmacies in the US?

Section 503A pharmacies (patient-specific compounding) are regulated mainly by state boards of pharmacy; Section 503B outsourcing facilities must register with the FDA, follow CGMP, and undergo FDA inspection ^[3]. Neither tier means the FDA pre-approves each compounded formulation the way it does for approved drugs.

Can I get enclomiphene without a prescription?

You shouldn't, and legitimately you can't through a licensed US pharmacy. Vendors selling enclomiphene with no medical evaluation are typically operating outside the pharmacy supply chain entirely, meaning no prescriber oversight and often no meaningful purity accountability behind the product.

What monitoring should happen while on enclomiphene?

Most protocols check baseline total and free testosterone, LH, FSH, and estradiol before starting, then recheck labs around 4 to 8 weeks in to confirm response and guide dose adjustments. If fertility is the specific goal, a baseline semen analysis is a reasonable ask, since testosterone normalization alone doesn't confirm sperm parameters are unaffected.

Sources

1. FDA, Repros Therapeutics Androxal regulatory history (company SEC/press disclosures referencing FDA Complete Response Letters): Enclomiphene (Androxal) received FDA Complete Response Letters and was never approved
2. FDA, Current Good Manufacturing Practice (CGMP) Regulations: Approved drugs are manufactured under FDA-inspected CGMP facilities with pre-market process review
3. FDA, Compounding and the FDA: Questions and Answers: 503A pharmacies are regulated primarily by state boards; 503B outsourcing facilities must register with FDA and follow CGMP
4. FDA, Registered Outsourcing Facilities: FDA maintains a public list of registered 503B outsourcing facilities
5. USP, General Chapters <795> and <797> Compounding Standards: USP <795>/<797> set non-sterile and sterile compounding quality standards including beyond-use dating
6. PubMed/NIH, pharmacology of clomiphene citrate isomers: Clomiphene citrate is approximately a 62:38 mixture of enclomiphene (trans) and zuclomiphene (cis) isomers
7. Endocrine Society, Testosterone Therapy in Men with Hypogonadism Clinical Practice Guideline: Exogenous testosterone therapy suppresses the hypothalamic-pituitary-gonadal axis and spermatogenesis
8. Journal of Sexual Medicine, enclomiphene vs. testosterone gel study: Small clinical study found enclomiphene raised testosterone while maintaining sperm concentration and gonadotropin levels compared to a testosterone gel arm